Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Erbitux

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Erbitux was produced by Merck & Co. and Bristol-Myers Squibb.

Daiichi pulls study of patritumab in lung cancer

Daiichi pulls study of patritumab in lung cancer Daiichi Sankyo is also testing patritumab in a phase II trial in head and neck cancer, in combination with Eli Lilly's EGFR inhibitor Erbitux (cetuximab) and platinum-based chemotherapy.

BMS claims 80% market share for Opdivo in US

BMS claims 80% market share for Opdivo in US revenues from the return of rights to colorectal cancer drug Erbitux (cetuximab) to Eli Lilly.

Priority review for Keytruda in head and neck cancer

Priority review for Keytruda in head and neck cancer double that seen with established head and neck cancer therapies such as Eli Lilly's Erbitux (cetuximab). ... Merck is also waiting to hear the results of the KEYNOTE-055, which will include patients whose cancer has progressed despite prior treatment

FDA verdict on Amgen's Humira biosimilar due in September

FDA verdict on Amgen's Humira biosimilar due in September Eli Lilly's colorectal/head and neck cancer therapy Erbitux (cetuximab) in earlier-stage trials, as well as three other undisclosed projects.

Cancer Drugs Fund axes 16 treatments after overspending

Cancer Drugs Fund axes 16 treatments after overspending Merck KGaA's Erbitux (cetuximab), and Janssen's Imbruvica (ibrutinib) are among the latest casualties of the stricter line being taken with the CDF by NHS England - whose latest round of

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Menopause-thumbnail.png
Breaking the silence: It’s time to talk about the menopause
Using findings from our latest opinion poll, Vicki Newlove outlines why the hidden landscape of menopause may finally be starting to change....
Committing time to making meaningful connections - top 5 tips
Read the second blog of the series looking at key barriers to effective patient engagement in pharma...
News:
Senior Analytics Specialist joins Research Partnership...